KM Financial Solutions | Judge shields OxyContin-maker Purdue from litigation until April
55088
post-template-default,single,single-post,postid-55088,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Judge shields OxyContin-maker Purdue from litigation until April

Judge shields OxyContin-maker Purdue from litigation until April

Purdue Pharma LP and the company’s Sackler
family owners will be shielded until April 8, 2020, from
sprawling opioid litigation to give the maker of OxyContin time
to try to reach a legal settlement the company says is worth $10
billion.

No Comments

Sorry, the comment form is closed at this time.